feed,title,long_url,short_url
SeekingAlpha,KalVista begins phase 3 trial of oral drug KVD900 to treat hereditary angioedema attacks,https://seekingalpha.com/news/3810094,
SeekingAlpha,Cargojet reports Q4 results,https://seekingalpha.com/news/3810095,
SeekingAlpha,"Russia's war in Ukraine rattles global shipping, rates could triple",https://seekingalpha.com/news/3810093,
SeekingAlpha,"Vectrus, Vertex enter all-stock merger pact",https://seekingalpha.com/news/3810092,
